- Report
- February 2024
- 175 Pages
Global
From €4766EUR$5,000USD£4,088GBP
- Report
- May 2024
- 164 Pages
Global
From €5194EUR$5,450USD£4,456GBP
- Report
- September 2023
- 145 Pages
Global
From €2382EUR$2,499USD£2,043GBP
- Report
- January 2024
- 200 Pages
Global
From €3955EUR$4,150USD£3,393GBP
- Report
- June 2023
- 158 Pages
Global
From €2383EUR$2,500USD£2,044GBP
- Report
- September 2023
- 124 Pages
North America
From €2572EUR$2,699USD£2,207GBP
- Report
- March 2024
- 194 Pages
Global
From €3216EUR$3,374USD£2,759GBP
€3573EUR$3,749USD£3,065GBP
- Report
- October 2023
- 75 Pages
Global
From €5671EUR$5,950USD£4,865GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1906EUR$2,000USD£1,635GBP
- Report
- October 2023
- 186 Pages
Global
From €5242EUR$5,500USD£4,497GBP
- Report
- March 2024
- 181 Pages
Global
From €3216EUR$3,374USD£2,759GBP
€3573EUR$3,749USD£3,065GBP
- Report
- March 2024
- 186 Pages
Global
From €3216EUR$3,374USD£2,759GBP
€3573EUR$3,749USD£3,065GBP
- Report
- May 2023
- 169 Pages
Global
From €2240EUR$2,350USD£1,921GBP
- Report
- March 2024
- 195 Pages
Global
From €3216EUR$3,374USD£2,759GBP
€3573EUR$3,749USD£3,065GBP
- Report
- January 2024
- 150 Pages
Global
From €4623EUR$4,850USD£3,965GBP
- Report
- October 2023
- 185 Pages
Global
From €4670EUR$4,900USD£4,006GBP
- Report
- November 2023
- 177 Pages
Global
From €4670EUR$4,900USD£4,006GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1906EUR$2,000USD£1,635GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1906EUR$2,000USD£1,635GBP
- Drug Pipelines
- April 2024
- 50 Pages
Global
From €1430EUR$1,500USD£1,226GBP
The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more